Application · Mass Spectrometry Imaging

MSI in Pathological Diagnosis: Overlaying a Molecular Map Under the Microscope

The core of pathological diagnosis is 'observing morphology, determining nature'. But for many diseases, molecular changes have already occurred before morphological changes appear. Mass spectrometry imaging (MSI) can present in-situ the spatial distribution of molecules such as lipids, metabolites, drugs and peptides on sections that preserve tissue structure, providing molecular evidence beyond morphology for pathological diagnosis, especially in biomarker discovery, early disease identification and grading.
Table of Contents
1. Positioning of MSI in Pathology2. Assisting Tumor Grading and Hormone-Receptor Status Judgment3. Microbiology, Bacteria and Infection-Related Pathology4. Integration Boundaries with Existing Pathology Workflows
Schematic principle: ion source ionizes the sample spot-by-spot Tissue section Sample Ionization beam MSI in Pathological Diagnosis: Overlaying a Molecular Map Under the Microscope Ions MS analyzer
MSI in Pathological Diagnosis: Overlaying a Molecular Map Under the Microscope — schematic diagram

1. Positioning of MSI in Pathology

In the application notes of the Neo-Source MSI DPI, pathological diagnosis is explicitly listed as a key area, covering disease biomarker discovery, early disease diagnosis, clinical pathology research, bacterial analysis, microbial imaging, determining tumor grade, hormone-receptor status, gene-chip detection, cell biology and microbial ecology. MSI provides molecular-species and coordinate information that can be registered with histological means such as H&E and IHC.

Its engineering advantages fit the pathology scenario: matrix-free, low ion suppression, tissue can be analyzed directly; 20–200 μm adjustable resolution; the section remains intact after imaging for continued H&E pathological testing, making the research chain of 'imaging first, staining validation later' smooth.

2. Assisting Tumor Grading and Hormone-Receptor Status Judgment

Determining tumor grade and judging hormone-receptor status are key steps in pathological diagnosis. By comparing molecular spectral differences between tumor and paratumor regions, MSI can identify molecules specifically enriched or absent as potential grading and receptor-related biomarkers. In a published DPI case, the melanocytic nevus region and normal tissue showed systematic differences in lipid spectral patterns, and the characteristic molecule distribution highly matched the H&E nevus region, exactly reflecting this approach.

It must be emphasized that MSI is mostly at the research and translation stage; entering formal diagnosis still requires standardization, cohort validation and regulatory approval; it already has clear value in 'assisting biomarker discovery', 'explaining mechanisms' and 'complementing existing diagnosis'.

3. Microbiology, Bacteria and Infection-Related Pathology

The DPI application notes also include bacterial analysis, microbial imaging and microbial ecology as pathology-related directions. For infection- or microbiota-related samples, MSI can distinguish different microorganisms or their metabolic features in-situ in tissue, assisting understanding of infection distribution and microecological structure, providing a molecular spatial perspective for infectious pathology research.

Matrix-free preparation makes such often diverse and complex sample-preparation scenarios easier to deploy: the two Neo-Source imaging sources are matrix-free and measure on demand, allowing pathology and testing personnel without MSI expertise to begin using them relatively quickly.

4. Integration Boundaries with Existing Pathology Workflows

MSI is not to replace the microscope or IHC, but to complement. In practice, MSI sections are often registered with adjacent H&E/IHC sections, overlaying molecular signals onto histological structures to form dual 'morphology + molecule' interpretation.

Engineered to be compatible with mainstream mass spectrometers from Agilent, AB SCIEX and Thermo, the two Neo-Source imaging sources provide a self-developed titanium-alloy ion transfer tube that does not damage the sample at the front end and is detachable for cleaning, supporting stable and reproducible pathology-related imaging research.

Frequently Asked Questions (FAQ)

Can mass spectrometry imaging replace the pathologist's microscope interpretation?
It cannot and should not. MSI provides molecular spatial distribution as supplementary evidence; formal diagnosis still relies on standard workflows such as histological morphology and IHC; it is outstanding in biomarker discovery and mechanism explanation.
In which steps is MSI most often used in pathology?
Mainly for disease biomarker discovery, early identification, tumor grading, hormone-receptor-status related molecular research, and in-situ analysis of bacteria/microbe-related pathology.
Why does the pathology scenario value matrix-free?
Pathology samples often require subsequent H&E or IHC validation; the matrix-free route eliminates spraying optimization, avoids matrix-peak interference, and the section remains intact for continued staining.
Can H&E still be done after imaging?
Yes. The Neo-Source DPI explicitly supports keeping the tissue section intact after imaging for continued H&E pathological testing, enabling registration between imaging and histology.

Get Specifications & Quotation

To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).

Related Articles

DPI Dual-Photoionization Imaging SourceNeo-Source MSI LDPI Laser Desorption Photoionization imaging ion sourceTumor Biomarker Localization: Placing 'Biomarkers' into the Real Space of TumorsClinical Pathology Diagnosis Applications: Overlaying a Molecular Map Under the MicroscopeImmunohistochemistry (IHC) and Mass Spectrometry Imaging

← Back to MSI Ion Source Knowledge Hub